YEAR-END REPORT VIGMED HOLDING AB JANUARY 1 – DECEMBER 31

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Feb 25, 2015 at 7:15 AM

YEAR-END REPORT VIGMED HOLDING AB JANUARY 1 – DECEMBER 31 2014

During the past year Vigmed has launched three new products in the market: CLiP® Ported, CLiP® Winged and CLiP® Neo. In December 2014 the Company received CE mark for the new product line SWiNG, which was then launched in January 2015. A new safety solution for arterial catheters - SWiTCH - is currently in its validation phase and will be ready for launch in September. The company has signed distribution agreements for most of the priority markets within EU and these distributors can now meet EU requirements of moving from non -safety to safety products by including Vigmed’s patented safety solutions in public tenders. Establishing presence in the European markets is currently in focus, at the same time products and partnerships for the US and China markets are being prepared. In December 2014, a rights issue of 6,261,904 new shares was conducted in which Vigmed Holding AB raised MSEK 52.1. This allows Vigmed to focus on market penetration and further develop innovative products. The organization has been strengthened by an additional five employees. Vigmed is now ready with a competent, experienced and well-motivated team to take the next step in the commercialization of Vigmed’s safety products. Financial information for the fourth quarter in brief · Net Sales for the fourth quarter amounted to kSEK 685 (0 SEK in 2013). · Operating profit in the fourth quarter for the Group amounted to MSEK -9.6 (MSEK -4.6). · Net income per weighted number of shares for the fourth quarter amounted to SEK -0.26 (SEK-0.12). · Cash flow from operating activities during the fourth quarter amounted to SEK -4.2 million (SEK -4.4 million). · Cash flow from investing activities during the fourth quarter amounted to MSEK -10.9 (MSEK -4.0). · Cash flow from financing activities during the fourth quarter amounted to MSEK 59.4 (MSEK -0.3). The positive cash flow from financing activities relates mainly to the rights issue of net MSEK 52.1. Financial information for the year in short · Net Sales for the year amounted to kSEK 1,124 (0 SEK during 2013). · Operating profit for the year for the Group amounted to MSEK -32.0 (MSEK -21.0). · Net income per weighted number of shares for the year amounted to SEK -0.85 (SEK-0.65). · Cash flow from operating activities during the year amounted to MSEK -20.9 (MSEK -23.3). · Cash flow from investing activities during the year amounted to MSEK -17.5 (MSEK -12.3). · Cash flow from financing activities amounted to MSEK 60.0 (MSEK 24.8). The financing relates mainly to the rights issue of MSEK 52.1. · Cash and cash equivalents at end of period amounted to MSEK 63.5 (MSEK 41.8). · The shareholders’ equity at the end of the period amounted to MSEK 73.8 (MSEK 53.4). The Board of Directors of Vigmed Holding AB For additional information please read the full Year-End Report For further information contact: Chairman of the board, Lennart Holm 46 70 630 8562 or CEO, Finn Ketler 46 42 600 5311 Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden, and has approximately 20 employees. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and has approximately 5 400 shareholders. Remium Nordic AB is the Company’s Certified Advisor. Additional information such as company description, a video presentation and risk factors can be found on Vigmed’s website: www.vigmed.com/investor

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Classic vs. Youngtimer Cars: Evolution in Collecting

The Collector's Journey: Classic Cars vs. Youngtimers Ever notice how car collecting has its own circles of fame? You're either basking in the glow of a vintage classic or eyeing a youngtimer that’s just catching steam. In this article from HelloNation, Engels Gualdani — the classic car sage of Hilton, NY — helps untangle these categories for us, and it’s a lesson...

Smart Banner Choices: Decisions Beyond Design

By Caleb Price Updated Nov 13, 2026 Category News Views 152

Location, Location, Location: Banner Insights Picking a banner isn't just a quick snap decision. You got to think big, and location is a starting line. Adam Norsworthy from Minuteman Press underscores that understanding how and where this piece of publicity will hang matters more than you might guess. Outdoor or indoor isn't just a weather question; it's a matter of...

PangeAI and Sky Blue Transform Data Center Decisions

Just when you thought the incessant trials of picking a prime data center site couldn’t get any more grueling or expensive, enter PangeAI and its brand-new ally, Sky Blue Impact. These tech firms have partnered up to speed up what has traditionally been a sluggish, pricey process. Here’s the deal: PangeAI’s geospatial AI platform lets Sky Blue dodge the usually...

Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Toys"R"Us Rolls Out 160 U.S. Stores, NYC Celebration

Rebuilding the Toy Empire After a rough few years, Toys"R"Us is clawing its way back into the hearts—and wallets—of American shoppers. With 160+ new standalone stores popping up like mushrooms after rain, these guys aren't just playing games. This is a strategic move to reestablish their presence in the retail landscape just before the holiday shopping frenzy kicks...

Nagarro's Earnings Show Stagnant Growth Amid Flat Margins

Nagarro's Financial Picture: A Glimpse Live a day in the trading pits and you'll learn to spot when a company is merely treading water. That's the vibe I'm getting from Nagarro's Q3 2026 results. They might label themselves as an AI-native leviathan, but these numbers spell out a story of struggle wrapped in fancy buzzwords. Revenue Uptick or Revenue Hiccup? For the nine...

APEC Summit 2026: Shenzhen in the Spotlight

An International Stage for Shenzhen Alright, folks, here's the deal. We’ve got the 2026 APEC Summit rolling into Shenzhen, perched right there in Guangdong Province, and the world’s eyes are glued to it. Happens November 18–19, and you better believe it’s a magnet for all things global. The China Media Group’s Chinese Global Program Center isn’t missing a...

Endava Faces Class Action: Investor Reactions and Next Steps

Trouble at Endava: Leadership Shakeup and Financial Concerns So, here's the kicker—Endava's got itself into one mighty mess worth chewing over with your morning coffee. When your top brass drops like flies, and you're fumbling your financials, investors start sweating bullets. On October 28, 2026, Endava plc (NYSE: DAVA) confesses to some serious accounting missteps....

First Horizon's $25M Bet: New Center Transforms Houston

New Markets Tax Credits: A Game Changer First things first, if you're thinking this is some typical charitable write-off, think again. First Horizon Bank (NYSE: FHN) is deep in the mix of something pretty transformative in the world of finance and community support. They're not just throwing money at a problem and hoping it sticks. Nope, we're talking real strategy with a...

Perpetua Reports Q3 2026 Results, Progress on Project

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...